OpenURL Connection Search

Select item for more details and to access through your institution.

Iron deficiency and thrombocytosis.
Published in:
Vox Sanguinis, 2017, v. 112, n. 1, p. 87, doi. 10.1111/vox.12454
By:
- Holbro, A.;
- Volken, T.;
- Buser, A.;
- Sigle, J. P.;
- Halter, J. P.;
- Passweg, J. R.;
- Tichelli, A.;
- Infanti, L.
Publication type:
Article
Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation.
Published in:
2015
By:
- Tschan-Plessl, A.;
- Halter, J.;
- Heim, D.;
- Medinger, M.;
- Passweg, J.;
- Gerull, S.;
- Halter, J P;
- Passweg, J R
Publication type:
journal article
Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1331, doi. 10.1038/bmt.2015.148
By:
- Binkert, L;
- Medinger, M;
- Halter, J P;
- Heim, D;
- Gerull, S;
- Holbro, A;
- Lengerke, C;
- Weisser, M;
- Passweg, J R
Publication type:
Article
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 1, p. 3, doi. 10.1038/bmt.2014.242
By:
- Frey Tirri, B;
- Häusermann, P;
- Bertz, H;
- Greinix, H;
- Lawitschka, A;
- Schwarze, C-P;
- Wolff, D;
- Halter, J P;
- Dörfler, D;
- Moffat, R
Publication type:
Article
Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 9, p. 1223, doi. 10.1038/bmt.2014.142
By:
- Kirsch, M;
- Götz, A;
- Halter, J P;
- Schanz, U;
- Stussi, G;
- Dobbels, F;
- De Geest, S
Publication type:
Article
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 220, doi. 10.1038/bmt.2012.119
By:
- Halter, J P;
- van Walraven, S M;
- Worel, N;
- Bengtsson, M;
- Hägglund, H;
- Nicoloso de Faveri, G;
- Shaw, B E;
- Schmidt, A H;
- Fechter, M;
- Madrigal, A;
- Szer, J;
- Aljurf, M D;
- Weisdorf, D;
- Horowitz, M M;
- Greinix, H;
- Niederwieser, D;
- Gratwohl, A;
- Kodera, Y;
- Confer, D
Publication type:
Article
Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 7, p. 981, doi. 10.1038/bmt.2011.205
By:
- Sabti, S;
- Halter, J P;
- Braun Fränkl, B C;
- Goldblum, D
Publication type:
Article

Found: 7

Iron deficiency and thrombocytosis.

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation.

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.

Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.

Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD.